Inventor · disambiguated record
Charles E. Prussak
Also filed as: PRUSSAK CHARLES · PRUSSAK CHARLES E · PRUSSAK CHARLES EDWARD
12 granted patents·7 pending applications·278 citations·filing 1993–2024
92Inventor score
Top patents by PatentIndex Score
19 records- 0195US11312787B2Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasisUNIV CALIFORNIA·Filed 2019·Granted Apr 26, 2022·8 cites·20 claims
- 0295US7928213B2Nucleic acids encoding chimeric CD154 polypeptidesUNIV CALIFORNIA·Filed 2009·Granted Apr 19, 2011·35 cites·17 claims
- 0393US7495090B2Nucleic acids encoding chimeric CD154 polypeptidesUNIV CALIFORNIA·Filed 2002·Granted Feb 24, 2009·45 cites·17 claims
- 0492US9758591B2Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasisUNIV CALIFORNIA·Filed 2013·Granted Sep 12, 2017·16 cites·8 claims
- 0589US7786282B2Nucleic acid molecules encoding TNF-α ligand polypeptides having a CD154 domainUNIV CALIFORNIA·Filed 2001·Granted Aug 31, 2010·17 cites·24 claims
- 0687US2025282888A1Antibodies and vaccines for use in treating ror1 cancers and inhibiting metastasisUNIV CALIFORNIA·Filed 2024·Application pending·0 cites
- 0786US10344096B2Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasisUNIV CALIFORNIA·Filed 2017·Granted Jul 9, 2019·4 cites·22 claims
- 0884US5447859AMethod for the purification or removal of retroviruses using sulfated celluloseVIAGENE INC·Filed 1993·Granted Sep 5, 1995·65 cites·5 claims
- 0980US12162950B2Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasisUNIV CALIFORNIA·Filed 2022·Granted Dec 10, 2024·0 cites·14 claims
- 1080US5739018APackaging cell lines for pseudotyped retroviral vectorsUNIV CALIFORNIA·Filed 1996·Granted Apr 14, 1998·52 cites·16 claims
- 1174US8138310B2Chimeric CD154 polypeptidesPRUSSAK CHARLES E·Filed 2011·Granted Mar 20, 2012·2 cites·2 claims
- 1271US7964712B2Chimeric nucleic acids encoding polypeptides comprising TNF alpha, CD70 and FAS ligand domainsUNIV CALIFORNIA·Filed 2010·Granted Jun 21, 2011·1 cites·26 claims
- 1367US2025381270A1Isolating active t-cell cars from bulk transduced human t-cellsUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 1464US5792643AMethods for preserving recombinant retrovirusesFiled 1997·Granted Aug 11, 1998·33 cites·35 claims
- 1559US2024415883A1Treatment of neuroendocrine cancersUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 1659US2024117047A1Monoclonal antibodies specific for human ror1UNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 1751US2023312708A1Chimeric antigen receptor modified t-cells (car-t) for the treatment of hematological and solid tumor cancersUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 1845US2012116052A1Nucleic Acid Molecules Encoding TNF-Alpha Ligand Polypeptides Having a CD154 DomainPRUSSAK CHARLES E·Filed 2011·Application pending·0 cites
- 1942US2008318886A1Methods of Increasing Cancer Sensitivity to Chemotherapeutic Agents Using Chimeric ISF35PRUSSAK CHARLES E·Filed 2007·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →